BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a naturally occurring protein found in human gastric juice called Body Protection Compound. Unlike most peptides, BPC-157 is remarkably stable in gastric acid, which is why researchers have explored both injectable and oral administration routes.
The peptide's primary mechanism involves upregulation of growth hormone receptors and activation of the FAK-paxillin signaling pathway, which promotes fibroblast migration and collagen deposition at injury sites. It also stimulates angiogenesis — the formation of new blood vessels — through VEGFR2 pathway activation, improving blood flow to damaged tissues.
In the nitric oxide (NO) system, BPC-157 appears to modulate NO synthase activity, which plays a role in inflammation regulation, blood vessel dilation, and tissue repair signaling. This multi-pathway approach is what makes BPC-157 one of the most broadly studied peptides in regenerative research.
BPC-157 has one of the most extensive preclinical research profiles of any peptide in the regenerative space. While human clinical trials remain limited, the volume of animal and in vitro data is substantial.
Tendon & Muscle Healing: In rat models with transected Achilles tendons, BPC-157 treatment increased biomechanical tendon strength and accelerated fibroblast outgrowth from tendon explants. Separate studies on quadriceps muscle injuries showed a 92% increase in biomechanical muscle strength after 72 hours compared to controls.
Gut Protection: In rats with colon-to-colon anastomosis, BPC-157 improved healing of colon defects, increasing bursting pressure by approximately 62% and biomechanical resistance by roughly 77% versus controls. Multiple studies have also demonstrated protective effects against NSAID-induced gastric lesions.
Neuroprotection: Research in spinal cord injury models showed BPC-157 treatment led to recovery of tail function, resolved spasticity, and counteracted axonal necrosis and demyelination. In traumatic brain injury models, the peptide reduced oxidative stress and neuronal loss in the hippocampus.
Bone Healing: Studies have demonstrated accelerated bone fracture healing with improved callus formation and bone mineral density at fracture sites.
The following protocols are reported from clinical practice. This is not medical advice. Consult a licensed healthcare provider before starting any peptide therapy.
Healthcare providers who prescribe BPC-157 typically use the following protocol frameworks. These are reported clinical approaches — not medical advice.
Injectable (Subcutaneous): 250–500 mcg per day, injected near the site of injury or subcutaneously in the abdominal area. Most providers recommend a cycle of 4–8 weeks, with some extending to 12 weeks for chronic conditions.
Oral (Capsule): 500–1,000 mcg per day, primarily for gastrointestinal applications. Some providers recommend 500 mcg twice daily for gut-specific protocols.
Common Stacks: BPC-157 is frequently combined with TB-500 (Thymosin Beta-4) in what's commonly called the "Wolverine Stack" for enhanced recovery. Providers also pair it with GHK-Cu for wound healing or KPV for gut inflammation protocols.
BPC-157 is generally considered well-tolerated in the research literature. Commonly reported effects include mild injection site redness or irritation (subcutaneous), occasional nausea at higher oral doses, mild headache during the first few days, and temporary dizziness in some individuals.
No serious adverse events have been documented in the published preclinical literature. However, the limited human clinical trial data means the long-term safety profile is not fully established. Individuals with active cancer or a history of cancer should exercise caution, as BPC-157's pro-angiogenic properties (stimulating new blood vessel growth) could theoretically promote tumor vascularization.
Verified suppliers with third-party testing and COA documentation. Use code POWER where applicable.
Yes. As of 2026, BPC-157 is classified as a Category 1 peptide by the FDA, meaning it is cleared for compounding by licensed pharmacies. It can be obtained through a prescription from a licensed healthcare provider or purchased as a research compound from qualified suppliers.
Injectable BPC-157 (subcutaneous) delivers the peptide directly to the bloodstream and is generally preferred for musculoskeletal injuries, tendon repair, and systemic applications. Oral BPC-157 is primarily used for gastrointestinal conditions like leaky gut, IBS, and NSAID-induced damage, as it acts locally in the digestive tract.
Most providers report that patients notice initial improvements within 1–2 weeks, with more significant results appearing at the 4–6 week mark. Tendon and ligament injuries may take longer (6–12 weeks) due to the slower nature of connective tissue repair.
Yes, BPC-157 is commonly stacked with TB-500 (the "Wolverine Stack") for enhanced recovery, with GHK-Cu for wound healing and skin repair, and with KPV for gut inflammation protocols. Providers typically design stacking protocols based on the specific condition being addressed.
Most providers recommend cycling BPC-157 with 4–8 weeks on followed by 2–4 weeks off. Some protocols for chronic conditions may run longer, but cycling helps maintain receptor sensitivity and is considered best practice in peptide therapy.
Take our 2-minute quiz to get a personalized peptide recommendation based on your goals, experience level, and health priorities.
Take the Peptide Quiz →This content is for informational and educational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, cure, or prevent any disease or condition. Always consult with a qualified healthcare provider before starting any peptide therapy or supplement regimen. Peptide protocols described on this page reflect reported clinical practices and published research — not recommendations. Individual results may vary. Read full disclaimer.
Affiliate Disclosure: PeptideOnline.co participates in affiliate programs with suppliers featured on this page. We may earn a commission on qualifying purchases at no additional cost to you. Our editorial content is independent and not influenced by affiliate relationships. Learn more.